|1.||Li, Xiangqiang: 1 article (03/2012)|
|2.||Fu, Xiang-Dong: 1 article (03/2012)|
|3.||Zhou, Yu: 1 article (03/2012)|
|4.||Rosenfeld, Michael G: 1 article (03/2012)|
|5.||Ding, Sheng: 1 article (03/2012)|
|6.||Qiu, Jinsong: 1 article (03/2012)|
|7.||Zhou, Hongyan: 1 article (03/2012)|
|8.||Li, Hairi: 1 article (03/2012)|
|9.||Wang, Dong: 1 article (03/2012)|
09/26/1970 - "Oral peruvoside was also effective in the treatment of congestive heart failure when used on a short-term as well as a long-term basis. "
06/01/1992 - "[Hemodynamic studies on the effects of peruvoside on congestive heart failure]."
09/26/1970 - "Haemodynamic studies with peruvoside in human congestive heart failure."
01/01/1967 - "Pharmacological evaluation of peruvoside, a new cardiac glycoside from Thevetia neriifolia with a note on its clinical trials in patients with congestive heart failure."
09/26/1970 - "It therefore seems that peruvoside is a useful cardiac glycoside in the management of congestive heart failure in man as a quick-acting intravenous preparation. "
05/01/1972 - "Mechanism of peruvoside-induced emesis."
|4.||Prostatic Neoplasms (Prostate Cancer)
03/20/2012 - "By initially applying this multitarget strategy to the pressing problem of hormone-refractory prostate cancer, which tends to be accelerated by the current antiandrogen therapy, we identify Peruvoside, a cardiac glycoside, which can potently inhibit both androgen-sensitive and -resistant prostate cancer cells without triggering severe cytotoxicity. "
11/01/1975 - "Such abnormalities and the unusual response of some patients to administration of peruvoside may reflect underlying myocardial dysfunction in patients with constrictive pericarditis. "
11/01/1975 - "Left ventricular ejection time index (LVETI) decreased in normal subjects (P less than 0.01) and in most patients with constrictive pericarditis, and increased marginally in those with myocardial dysfunction (NS) after peruvoside administration. "
11/01/1975 - "Systolic time intervals were studied in 9 patients with documented constrictive pericarditis before and 15 to 20 minutes after intravenous administration of peruvoside (a quick acting digitalis-like glycoside) to determine underlying myocardial dysfunction. "
11/01/1975 - "The response of one patient with constrictive pericarditis to parenteral peruvoside administration was similar to that seen in patients with myocardial failure. "
11/01/1975 - "Pre-ejection period index (PEPI) shortened significantly (P less than 0.01) after peruvoside in normal subjects and in patients with myocardial failure, but not in constrictive pericarditis. "